Clínica e Investigación en Arteriosclerosis (English Edition): Volume 34 (Issue 1 to Issue 6)

11. Patient-Centric Approach: Clínica e Investigación en Arteriosclerosis recognizes the importance of a patient-centric perspective in addressing arteriosclerosis. Articles published in the journal often consider the broader implications of research and clinical practices on patient outcomes, contributing to a holistic understanding of cardiovascular health.
12. Ethical Considerations: Upholding ethical standards in research and practice is paramount for Clínica e Investigación en Arteriosclerosis. The journal emphasizes the ethical conduct of studies, ensuring that the rights and well-being of participants are prioritized and that research contributes positively to medical knowledge and patient care.
13. Impact on Healthcare Policy: The journal’s coverage extends to issues of healthcare policy, providing insights into how research findings and advancements in arteriosclerosis may influence policy decisions. This aspect underscores the societal impact of the journal and its role in shaping healthcare practices.
14. Global Relevance: While rooted in Spanish-speaking regions, the journal’s global relevance is evident in its contribution to the international dialogue on arteriosclerosis. Through collaborations, shared research, and participation in global conferences, Clínica e Investigación en Arteriosclerosis fosters a sense of interconnectedness in the global medical community.
15. Innovative Approaches: The journal remains at the forefront of innovation in cardiovascular research and clinical practices. By featuring cutting-edge studies and exploring emerging technologies, Clínica e Investigación en Arteriosclerosis ensures that its readers are informed about the latest developments that may shape the future of arteriosclerosis management.

In conclusion, Clínica e Investigación en Arteriosclerosis continues to evolve as a dynamic and influential force in the cardiovascular field. Its commitment to ethical research, patient-centered perspectives, and global collaboration positions the journal as an essential resource for healthcare professionals and researchers dedicated to advancing knowledge and improving outcomes in arteriosclerosis and related disciplines.

Volume 34, Supplement 1, Pages 1-36 (July 2022)

Volume 34, Issue 1: Pages 1-56 (January–February 2022)

Volume 34, Issue 2: Pages 57-104 (March–April 2022)

Volume 34, Issue 3: Pages 105-182 (May–June 2022)

Volume 34, Issue 4: Pages 183-244 (July–August 2022)

Volume 34, Issue 5: Pages 245-290 (September–October 2022)

Volume 34, Issue 6: Pages 291-338 (November–December 2022)